Cozart wins UK contract for drug abuse sample testing

10 June 2007

l Abingdon, Oxfordshire-based medical diagnostics company Cozart has won a contract with the UK Home Office, for the laboratory confirmation testing of oral fluid samples for the presence of drugs of abuse. The initial contract, for one year, is based on a four-year framework agreement between Cozart and the Home Office, established following a competitive tendering process. Cozart has been selected as the sole supplier to the Home Office for this first annual contract. First-year revenue will be L700,000 ($1.3 million).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight